They are not involved in day to day activities but I think these 2 board members are not " babes in the woods ".
At least I'm betting they aren't
Board Members (Strategic Oversight)
Gaurav Aggarwal, M.D. (Director, Vivo Capital): Brings extensive experience in healthcare M&A and venture capital. He previously served as Chief Business Officer at Ocera Therapeutics and has sat on boards of companies successfully acquired by major firms like GSK and Horizon Pharma.
Sandeep “Steve” Laumas, M.D. (Director): Began his career at Goldman Sachs in healthcare investment banking, specifically working on mergers & acquisitions and corporate finance transactions. He provides veteran guidance on the valuation of UNCY in potential buyout scenarios.
Kiwi
Market Data 
Markets 
AI
